DAWN
Price
$6.47
Change
-$0.01 (-0.15%)
Updated
Jun 27 closing price
Capitalization
655.82M
44 days until earnings call
GERN
Price
$1.48
Change
-$0.05 (-3.27%)
Updated
Jun 27 closing price
Capitalization
942.64M
39 days until earnings call
Interact to see
Advertisement

DAWN vs GERN

Header iconDAWN vs GERN Comparison
Open Charts DAWN vs GERNBanner chart's image
Day One Biopharmaceuticals
Price$6.47
Change-$0.01 (-0.15%)
Volume$4.32M
Capitalization655.82M
Geron
Price$1.48
Change-$0.05 (-3.27%)
Volume$16.33M
Capitalization942.64M
DAWN vs GERN Comparison Chart in %
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. GERN commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Buy and GERN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (DAWN: $6.47 vs. GERN: $1.49)
Brand notoriety: DAWN and GERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 309% vs. GERN: 149%
Market capitalization -- DAWN: $655.82M vs. GERN: $942.64M
DAWN [@Biotechnology] is valued at $655.82M. GERN’s [@Biotechnology] market capitalization is $942.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileGERN’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • GERN’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 3 TA indicator(s) are bullish while GERN’s TA Score has 6 bullish TA indicator(s).

  • DAWN’s TA Score: 3 bullish, 5 bearish.
  • GERN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, GERN is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а +2.37% price change this week, while GERN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

DAWN is expected to report earnings on Aug 12, 2025.

GERN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GERN($943M) has a higher market cap than DAWN($656M). DAWN YTD gains are higher at: -48.934 vs. GERN (-57.910). GERN has higher annual earnings (EBITDA): -114.49M vs. DAWN (-188.76M). DAWN has more cash in the bank: 473M vs. GERN (397M). DAWN has less debt than GERN: DAWN (2.92M) vs GERN (122M). DAWN has higher revenues than GERN: DAWN (162M) vs GERN (116M).
DAWNGERNDAWN / GERN
Capitalization656M943M70%
EBITDA-188.76M-114.49M165%
Gain YTD-48.934-57.91085%
P/E RatioN/AN/A-
Revenue162M116M140%
Total Cash473M397M119%
Total Debt2.92M122M2%
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNGERN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 23 days ago
80%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 6 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGFSX18.440.14
+0.77%
Gabelli Global Financial Services A
VAFRX29.030.22
+0.76%
Invesco American Franchise R
STFBX89.920.20
+0.22%
State Farm Balanced
ECRAX14.660.03
+0.21%
Eaton Vance RBA All Asset Strategy Fd C
ETHSX12.73-0.03
-0.24%
Eaton Vance Worldwide Health Sci A

GERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
-2.61%
SER - GERN
66%
Loosely correlated
+0.65%
LIANY - GERN
53%
Loosely correlated
+1.18%
VCYT - GERN
44%
Loosely correlated
+2.13%
MIRM - GERN
39%
Loosely correlated
+1.05%
DAWN - GERN
37%
Loosely correlated
-0.15%
More